RxNorm Semantic Concepts Index - 182
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "182".
RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
---|---|---|---|---|
RxCUI: 182182 | Fatty-acid methyltransferase | Designated preferred name (PT) | NO | |
RxCUI: 182182 | Fatty-acid methyltransferase | Full form of descriptor (FN) | NO | |
RxCUI: 18225 | Arabitol | Designated preferred name (PT) | NO | |
RxCUI: 18225 | Arabitol | Full form of descriptor (FN) | NO | |
RxCUI: 18225 | Arabitol | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 18228 | 5-HPETE | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 18228 | 5-HPETE | Designated preferred name (PT) | NO | |
RxCUI: 18228 | 5-HPETE | Full form of descriptor (FN) | NO | |
RxCUI: 18235 | Groundnut oil | Designated preferred name (PT) | YES | |
RxCUI: 18235 | Groundnut oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 18235 | Groundnut oil | Full form of descriptor (FN) | YES | |
RxCUI: 18235 | Groundnut oil | Designated preferred name (PT) | YES | |
RxCUI: 18235 | Groundnut oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 18235 | Groundnut oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 18235 | Groundnut oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 18235 | Groundnut oil | Full form of descriptor (FN) | YES | |
RxCUI: 1825 | Buserelin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1825 | Buserelin | Designated preferred name (PT) | YES | |
RxCUI: 1825 | Buserelin | Full form of descriptor (FN) | YES | |
RxCUI: 1825 | Buserelin | Designated preferred name (PT) | YES | |
RxCUI: 1825 | Buserelin | Full form of descriptor (FN) | YES | |
RxCUI: 18251 | Argemone oil | Designated preferred name (PT) | NO | |
RxCUI: 18251 | Argemone oil | Full form of descriptor (FN) | NO | |
RxCUI: 18254 | arginine aspartate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 18254 | arginine aspartate | Designated preferred name (PT) | NO | |
RxCUI: 18254 | arginine aspartate | Full form of descriptor (FN) | NO | |
RxCUI: 18258 | Arginine decarboxylase | Designated preferred name (PT) | NO | |
RxCUI: 18258 | Arginine decarboxylase | Full form of descriptor (FN) | NO | |
RxCUI: 18259 | Arginine dihydrolase | Designated preferred name (PT) | NO | |
RxCUI: 18259 | Arginine dihydrolase | Full form of descriptor (FN) | NO | |
RxCUI: 18259 | Arginine dihydrolase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 182649 | Phosphoenolpyruvate phosphatase | Designated preferred name (PT) | NO | |
RxCUI: 182649 | Phosphoenolpyruvate phosphatase | Full form of descriptor (FN) | NO | |
RxCUI: 1827 | Buspirone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1827 | Buspirone | Designated preferred name (PT) | YES | |
RxCUI: 1827 | Buspirone | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1827 | Buspirone | Full form of descriptor (FN) | YES | |
RxCUI: 1827 | Buspirone | Designated preferred name (PT) | YES | |
RxCUI: 1827 | Buspirone | Full form of descriptor (FN) | YES | |
RxCUI: 18279 | Arginyltransferase | Designated preferred name (PT) | NO | |
RxCUI: 18279 | Arginyltransferase | Full form of descriptor (FN) | NO | |
RxCUI: 1828 | Busulfan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1828 | Busulfan | Designated preferred name (PT) | YES | |
RxCUI: 1828 | Busulfan | Full form of descriptor (FN) | YES | |
RxCUI: 1828 | Busulfan | Designated preferred name (PT) | YES | |
RxCUI: 1828 | Busulfan | British synonym (SYGB) | British synonym of another TTY, given for clarity. | YES |
RxCUI: 1828 | Busulfan | Full form of descriptor (FN) | YES | |
RxCUI: 182810 | 3-hydroxyphenylacetate 6-monooxygenase | Designated preferred name (PT) | NO | |
RxCUI: 182810 | 3-hydroxyphenylacetate 6-monooxygenase | Full form of descriptor (FN) | NO | |
RxCUI: 182810 | 3-hydroxyphenylacetate 6-monooxygenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 182835 | N-acetylneuraminylgalactosylglucosylceramide beta-1,4-N-acetylgalactosaminyltransferase | Designated preferred name (PT) | NO | |
RxCUI: 182835 | N-acetylneuraminylgalactosylglucosylceramide beta-1,4-N-acetylgalactosaminyltransferase | Full form of descriptor (FN) | NO | |
RxCUI: 1829 | butacaine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1829 | butacaine | Designated preferred name (PT) | NO | |
RxCUI: 1829 | butacaine | Full form of descriptor (FN) | NO | |
RxCUI: 1829 | butacaine | Designated preferred name (PT) | NO | |
RxCUI: 1829 | butacaine | Full form of descriptor (FN) | NO | |
RxCUI: 18296 | Aristolochic acid | Designated preferred name (PT) | NO | |
RxCUI: 18296 | Aristolochic acid | Full form of descriptor (FN) | NO | |
RxCUI: 182976 | Coagulation factor X Friuli variant | Designated preferred name (PT) | NO | |
RxCUI: 182976 | Coagulation factor X Friuli variant | Full form of descriptor (FN) | NO |